Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
11%
Adrenergic Receptors
9%
Adverse Cardiac Remodeling
14%
AKT1
10%
Apoptosis
14%
Calves
10%
Cardiac Dysfunction
10%
Cardiac Function
21%
Cardiac Hypertrophy
14%
Cardiac Remodeling
13%
Cardiomyocytes
32%
Cardiomyopathy
12%
Cardioprotection
12%
Cardiovascular Disease
16%
CD4+ T
10%
Cell Culture Model
12%
Endothelial Cell Culture
12%
Estimated Glomerular Filtration Rate
13%
Failing Heart
17%
Fibrosis
11%
Hazard Ratio
10%
Heart Failure
99%
Heart Failure with Preserved Ejection Fraction (HFpEF)
16%
Heme oxygenase-1 (HO-1)
10%
Hypertrophy
14%
Inducible Nitric Oxide Synthase
12%
Inflammation
26%
Interleukin-18 (IL-18)
15%
Interleukin-1β
12%
Ischemia-reperfusion Injury
9%
Ischemic Heart Failure
17%
Left Ventricle
10%
Left Ventricular Dysfunction
10%
Left Ventricular Function
32%
Left Ventricular Remodeling
16%
Macrophages
12%
Medicare Beneficiaries
12%
Myocardial Infarction
34%
Myocardium
13%
Myocytes
12%
N-terminal pro-B-type Natriuretic Peptide (NT-proBNP)
9%
NF-B
10%
Nitric Oxide
13%
Nuclear factor-B
10%
O-linked N-acetylglucosamine (O-GlcNAc)
14%
Oxidative Stress
10%
Pathological Remodeling
10%
Post-myocardial Infarction
16%
Pressure Overload
19%
Tumor Necrosis Factor-α
12%
Pharmacology, Toxicology and Pharmaceutical Science
Acrolein
16%
Acute Coronary Syndrome
6%
Adrenergic Receptor
10%
Aldehyde
12%
All Cause Mortality
7%
Alternative Complement Pathway C3 C5 Convertase
10%
Angiotensin II
7%
Aortic Constriction
10%
Arachidonate 15 Lipoxygenase
9%
Beta Adrenergic Receptor Blocking Agent
6%
Calcium Ion
14%
Cardiotoxicity
7%
Cardiovascular Disease
7%
Cerebrovascular Accident
6%
Congestive Cardiomyopathy
7%
Congestive Heart Failure
100%
Cytokine
13%
Diseases
7%
Doxorubicin
7%
Eptifibatide
6%
Fibrosis
10%
Glutathione
6%
Heart Infarction
34%
Heart Left Ventricle Failure
8%
Heart Muscle Fibrosis
6%
Heart Muscle Ischemia
10%
Heart Ventricle Hypertrophy
7%
Heart Ventricle Remodeling
36%
Heme Oxygenase 1
9%
Hypertension
7%
Infarction
19%
Inflammation
27%
Interleukin 1
8%
Interleukin 18
6%
Ischemic Cardiomyopathy
6%
Isoprenaline
6%
Messenger RNA
6%
Myocardial Disease
13%
Nicotinamide Adenine Dinucleotide Phosphate
6%
Nitric Oxide
13%
Nuclear Factor
10%
Oxidoreductase
6%
Rat
6%
Reperfusion Injury
6%
Systolic Heart Failure
6%
Ticagrelor
6%
Transferase
6%
Tumor Necrosis Factor
8%
Tumor Necrosis Factor Receptor
6%
Wild Type Mouse
6%
Medicine and Dentistry
Aortic Constriction
6%
Apoplexy
7%
Beta Adrenergic Receptor Blocking Agent
6%
Calcium Ion
7%
Cardiac Fibrosis
7%
Cardiac Muscle Cell
16%
Cardiac Pathology
6%
Cardiovascular Disease
17%
Cardiovascular Mortality
6%
Cardiovascular Risk
6%
Cardiovascular System
6%
Cell Culture
13%
Chronic Kidney Disease
5%
Clinical Trial
5%
Congestive Heart Failure
61%
Coronary Artery Disease
10%
Coronary Circulation
6%
Counterpulsation
9%
Echocardiography
7%
Endothelial Cell
11%
Fibrosis
7%
Heart Failure with Preserved Ejection Fraction
9%
Heart Function
24%
Heart Graft
6%
Heart Left Ventricle Failure
5%
Heart Left Ventricle Function
8%
Heart Muscle Ischemia
14%
Heart Ventricle Remodeling
16%
Hemodynamic
25%
In Vitro
11%
Infarction
11%
Inflammation
22%
Inotropism
6%
Interleukin 1
6%
Ischemic Cardiomyopathy
6%
Left Ventricle
9%
Left Ventricular Assist Device
7%
Leukocyte
8%
Macrophage
7%
Meta-Analysis
6%
Monocyte
6%
Myocardial Disease
8%
Myocardial Infarction
13%
Myocardium
7%
Nitric Oxide
7%
Programmed Cell Death
7%
Ryanodine
6%
Systolic Heart Failure
6%
Tachyarrhythmia
6%
Ventricular Assist Device
12%